54 related articles for article (PubMed ID: 19728921)
1. Overall survival and short-term efficacy analysis of cervical squamous cell carcinoma with skeletal muscle and
Zhang J; Niu S; Lu X; Hu R; Wu Z; Yang S; Liu H
Sci Rep; 2024 Feb; 14(1):4809. PubMed ID: 38413662
[TBL] [Abstract][Full Text] [Related]
2. Clinical Significance of Serum SCC Levels Before Treatment for Locally Advanced Cervical Squamous Cell Carcinoma.
Yamaoka Y; Tamura S; Yamanoi K; Taki M; Murakami R; Yamaguchi K; Hamanishi J; Mandai M
Anticancer Res; 2024 May; 44(5):2009-2019. PubMed ID: 38677756
[TBL] [Abstract][Full Text] [Related]
3.
Milojevic IG; Milojevic B; Sobic-Saranovic D; Pantic N; Zivanovic J; Artiko VM
Hell J Nucl Med; 2023; 26(2):99-107. PubMed ID: 37527045
[TBL] [Abstract][Full Text] [Related]
4. PET/CT scan improves detection of metastatic disease compared with CT scan alone in women with high-grade neuroendocrine cervical cancer: a NeCTuR study.
Frumovitz M; Morani AC; Aziz A; Jhingran A; Ramalingam P; Gonzales NR; Salvo G; Sun J; Bhosale P
Int J Gynecol Cancer; 2023 Nov; 33(11):1690-1694. PubMed ID: 37875320
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of delayed complete metabolic response on PET/CT after primary chemoradiation treatment of cervical cancer.
Michaan N; Wenkert A; Even-Sapir E; Kerzhner K; Rabin T; Safra T; Peleg-Hasson S; Baruch Y; Raz Y; Grisaru D; Laskov I
Int J Gynecol Cancer; 2023 Nov; 33(11):1695-1701. PubMed ID: 37657818
[TBL] [Abstract][Full Text] [Related]
6. Impact of 18 F-FDG PET on the Management in Patients With Recurrent Gynecologic cancer : A Meta-analysis.
Pak K; Yoon HJ
Clin Nucl Med; 2023 Nov; 48(11):945-949. PubMed ID: 37756472
[TBL] [Abstract][Full Text] [Related]
7. Unusual Case of Primary Hepatic Squamous Carcinoma on 18F-FDG PET/CT.
Li W; Liu Z; Zhang R
Clin Nucl Med; 2023 Dec; 48(12):e596-e597. PubMed ID: 37934713
[TBL] [Abstract][Full Text] [Related]
8. The insufficiency of CT examination in early detection of central lung squamous cell carcinoma and squamous epithelial precancerous lesions.
Zhou J; Yu B; Guo P; Wang S
BMC Cancer; 2024 Mar; 24(1):299. PubMed ID: 38443800
[TBL] [Abstract][Full Text] [Related]
9. Tumor-Specificity Growth Factor Combined with Tumor Markers in Nuclear Medicine Imaging to Identify Prostate Cancer Osteonosus.
Zhang X; Chen Z
J Healthc Eng; 2021; 2021():7380120. PubMed ID: 34925738
[TBL] [Abstract][Full Text] [Related]
10. PET/CT Examination of Teratomas after Stem Cell Transplantation for a Spinal Cord Injury: A Case Report.
Chi XT; Tian J; Zhao XY; Zhang XY; Xu C; Deng K
Curr Med Imaging; 2024; 20():1-7. PubMed ID: 38389353
[TBL] [Abstract][Full Text] [Related]
11. The Application Value of CT Three-Dimensional Microscope Reconstruction Technology in the Diagnosis of Cervical Cancer.
Sun S; Wang X; Chen Y
Scanning; 2022; 2022():5648195. PubMed ID: 35800205
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of surveillance serum squamous cell carcinoma antigen for cervical cancer recurrence after definitive chemoradiation.
Shi V; Grover S; Huang Y; Thaker PH; Kuroki LM; Powell MA; Mutch DG; Contreras JA; Schwarz JK; Grigsby PW; Markovina S
Int J Gynecol Cancer; 2024 Apr; ():. PubMed ID: 38684343
[TBL] [Abstract][Full Text] [Related]
13. Current status and prospect of PET-related imaging radiomics in lung cancer.
Tang X; Wu F; Chen X; Ye S; Ding Z
Front Oncol; 2023; 13():1297674. PubMed ID: 38164195
[TBL] [Abstract][Full Text] [Related]
14. The Value of Surveillance Imaging of Oral Squamous Cell Carcinoma.
Bissinger O; Von den Hoff A; Maier E; Obermeier KT; Stimmer H; Kolk A; Wolff KD; Götz C
Cancers (Basel); 2024 Jan; 16(1):. PubMed ID: 38201635
[TBL] [Abstract][Full Text] [Related]
15. PET/CT morphology combined with metabolic imaging in the diagnosis of recurrence and metastasis of cervical cancer after type B radical trachelectomy.
Wu M; Cai P; Chen Z; Zhang B; Hou Z; Zhang X
Panminerva Med; 2019 Oct; ():. PubMed ID: 31670496
[No Abstract] [Full Text] [Related]
16. A solitary bronchial squamous cell papilloma with increased 18-fluorodeoxyglucose uptake and high serum levels of squamous cell carcinoma antigen.
Himuro N; Niiya Y; Minakata T; Oshima Y; Kataoka D; Tazawa S; Kadokura M
J Thorac Dis; 2018 Jun; 10(6):E435-E437. PubMed ID: 30069399
[No Abstract] [Full Text] [Related]
17. Comparison of
Sawicki LM; Kirchner J; Grueneisen J; Ruhlmann V; Aktas B; Schaarschmidt BM; Forsting M; Herrmann K; Antoch G; Umutlu L
Eur J Nucl Med Mol Imaging; 2018 Apr; 45(4):622-629. PubMed ID: 29164299
[TBL] [Abstract][Full Text] [Related]
18. Clinical Usefulness of (18)F-FDG PET/CT in the Detection of Early Recurrence in Treated Cervical Cancer Patients with Unexplained Elevation of Serum Tumor Markers.
Chong A; Ha JM; Jeong SY; Song HC; Min JJ; Bom HS; Choi HS
Chonnam Med J; 2013 Apr; 49(1):20-6. PubMed ID: 23678473
[TBL] [Abstract][Full Text] [Related]
19. [Application of 18F-FDG PET/CT in cervical cancer with elevated levels of serum squamous cell carcinoma antigen during the follow-up].
Hu YY; Sun XR; Lin XP; Liang PY; Zhang X; Fan W
Ai Zheng; 2009 Sep; 28(9):994-9. PubMed ID: 19728921
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]